Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare ... NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana. Mehr anzeigen
RED has been designed to duplicate test performance of traditional balloon expulsion test (BET) and manual sensation testing devices without needing electronics or software. NeurAxis Inc. will...
CARMEL, Ind., Nov. 12, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for...
CARMEL, Ind., Nov. 05, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies...
CARMEL, Ind., Nov. 04, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies...
CARMEL, Ind., Oct. 29, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies...
CARMEL, Ind., Oct. 22, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.05 | -2.02429149798 | 2.47 | 2.88 | 2.35 | 24911 | 2.3933344 | CS |
| 4 | -0.27 | -10.0371747212 | 2.69 | 3.34 | 2.25 | 37118 | 2.5024039 | CS |
| 12 | -0.48 | -16.5517241379 | 2.9 | 3.78 | 2.05 | 25796 | 2.71311785 | CS |
| 26 | -0.45 | -15.6794425087 | 2.87 | 3.78 | 2.05 | 14976 | 2.77327012 | CS |
| 52 | -0.12 | -4.72440944882 | 2.54 | 3.89 | 2.0001 | 12823 | 2.873792 | CS |
| 156 | -3.88 | -61.5873015873 | 6.3 | 6.93 | 1.8 | 20081 | 3.40176331 | CS |
| 260 | -3.88 | -61.5873015873 | 6.3 | 6.93 | 1.8 | 20081 | 3.40176331 | CS |
| Symbol | Preis | Vol. |
|---|---|---|
| OPTTOcean Power Technologies Inc | US$ 1,22 (9,91%) | 2,19M |
| CTMCastellum Inc | US$ 1,98 (18,56%) | 1,86M |
| SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 31,38 (5,23%) | 1,72M |
| MSTUT Rex 2X Long MSTR Daily Target ETF | US$ 10,69 (4,80%) | 1,2M |
| SOXSDirexion Daily Semiconductor Bear 3X Shares New | US$ 19,40 (-4,95%) | 945,31k |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
